NICE launched a new 5-year strategy for 2021-2026

27

Apr 2021

On April 19, 2021, NICE presented a new 5-year strategic plan at the virtual event. NICE provided clarifications and answered the questions on its strategy for 2021-2026, published in April.

Four pillars were identified to enable the NICE 5-year strategy. They represent the areas where NICE has the most significant impact. NICE will progress delivery of these alongside "business as usual."

  • Pillar 1 "Rapid, robust, and responsive technology evaluation;"
  • Pillar 2 "Dynamic, living guideline recommendations;"
  • Pillar 3 "Effective guidance uptake to maximize the NICE impact;"
  • Pillar 4 "Leadership in data, research, and science."

Among many other things, the following plans were announced:

  • To increase NICE' role as an enabler of market access for innovative technologies;
  • To develop robust and responsive methods and processes for the rapid evaluation of new and emerging products, including diagnostics, Medtech, digital health, genomics, and "hybrid" technologies, and increase the proportion of these technologies' assessments;
  • To move from producing full guidelines to a more modular, living approach of recommendations or clusters of recommendations, enabling rapid updates and a more efficient process. NICE will develop selected guidelines in a new interactive format in 2021/22;
  • To focus on collaboration, including earlier engagement with the industry while developing guidelines. The launch of the beta version of the new life sciences hub is scheduled for 2021/22;
  • To launch new Office for Digital Health that scheduled for 2021/22.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

12

May 2021

The Agency for Health Technology Assessment of Andalusia Autonomous Community in Spain (AETSA) systematically evaluates healthcare technologies and provides decision-makers with critically review information about their efficacy, safety, and effectiveness. Currently, the AETSA is working on assessments of laser-induced heat therapy in epilepsy surgery, stereotactic radiation therapy for the treatment of refractory ventricular tachycardia, implantable Holter monitor with ILink Online technology for prolonged cardiac monitoring, and other topics.

Read more

10

May 2021

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 6462 of April 21, 2021, Tuscany Regional Healthcare has published assessments of six medical devices of various therapeutic areas, including devices for the treatment of vaginal prolapse, cardiovascular conditions, an implant for vocal cord rehabilitation, and a cerebral embolic protective device.

Read more

06

May 2021

The Treatment Council (Behandlingsråd) is a new model for assessing treatment methods and health technologies, expected to become fully operational during 2021. The first meeting of the Treatment Council is planned to be conducted in May 2021. On April 15, 2021, the method and process frameworks of the Treatment Council (Behandlingsråd) were sent for consultation to the parties who have previously submitted consultation responses regarding these documents.

Read more

04

May 2021

In April 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0176 and 0073 with changes to be implemented not later than August 01, 2021. Four new procedure codes related to men's health and breast surgery and one new companion diagnostic code were introduced.

Read more

30

Apr 2021

The National Institute for Health and Care Excellence (NICE) is currently developing health technology assessments concerning eHealth technologies in its Medical Technologies Guidance, Diagnostic Guidance, and Medtech Innovation Briefing programs. As of late April 2021, there are thirteen ongoing assessments.

Read more